A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.
about
Risk of selected gastrointestinal and hepatic toxicities in cancer patients treated with nintedanib: a meta-analysis.Characterization of FGFR signaling pathway as therapeutic targets for sarcoma patientsFGFR gene alterations in lung squamous cell carcinoma are potential targets for the multikinase inhibitor nintedanib.Focus on Nintedanib in NSCLC and Other TumorsPhase I study of nintedanib in Japanese patients with advanced hepatocellular carcinoma and liver impairment.A phase II evaluation of brivanib in the treatment of persistent or recurrent carcinoma of the cervix: An NRG Oncology/Gynecologic Oncology Group study.Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma.
P2860
Q30249619-08E4BCFE-0969-4D43-9EC3-3DF7D766689DQ37094042-9821F95E-6CF9-4530-9700-9111A6DD5381Q37462489-26487D21-9C78-4C31-A96F-BB09349AAD25Q37512962-873E1FF3-7F94-4D42-B275-E26601E96032Q37544401-7CECC2DE-1140-4EDF-AFC0-F328C493FDB8Q38669565-4D507E32-9C9F-47E5-8FA8-7981A62BDEEBQ38754136-93209B01-93DA-4A88-871E-24F76478E731
P2860
A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
A randomised, phase II study o ...... l cell cancer: 3-year results.
@ast
A randomised, phase II study o ...... l cell cancer: 3-year results.
@en
type
label
A randomised, phase II study o ...... l cell cancer: 3-year results.
@ast
A randomised, phase II study o ...... l cell cancer: 3-year results.
@en
prefLabel
A randomised, phase II study o ...... l cell cancer: 3-year results.
@ast
A randomised, phase II study o ...... l cell cancer: 3-year results.
@en
P2093
P2860
P356
P1476
A randomised, phase II study o ...... l cell cancer: 3-year results.
@en
P2093
A-B Loembé
H Dressler
M Mazurkiewicz
P2860
P2888
P304
P356
10.1038/BJC.2015.313
P407
P577
2015-10-08T00:00:00Z
P5875
P6179
1025323676